Stimulating effect of terfenadine on erythrocyte cell membrane scrambling

Cellular Physiology and Biochemistry

Volumn 38, Issue 4, 2016, Pages 1425-1434

  Signoretto, Elena ^a,b   Castagna, Michela ^b   Al Mamun Bhuyan, Abdulla ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Calcium; Eryptosis; Ionomycin; Phosphatidylserine; Terfenadine

Indexed keywords

CALCIUM ION; CERAMIDE; DICHLORODIHYDROFLUORESCEIN DIACETATE; HEMOGLOBIN; LIPOCORTIN 5; PHOSPHATIDYLSERINE; REACTIVE OXYGEN METABOLITE; TERFENADINE; CALCIUM; CALCIUM IONOPHORE; HISTAMINE H1 RECEPTOR ANTAGONIST; IONOMYCIN;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ERYTHROCYTE MEMBRANE; ERYTHROCYTE VOLUME; FLOW CYTOMETRY; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; CYTOLOGY; DRUG EFFECTS; ERYPTOSIS; ERYTHROCYTE; METABOLISM;

CALCIUM; CALCIUM IONOPHORES; CERAMIDES; ERYPTOSIS; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; FLOW CYTOMETRY; HEMOLYSIS; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; IONOMYCIN; PHOSPHATIDYLSERINES; REACTIVE OXYGEN SPECIES; TERFENADINE;

EID: 84964040124     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000443085     Document Type: Article

References (77)

1. Chen C. Some pharmacokinetic aspects of the lipophilic terfenadine and zwitterionic fexofenadine in humans. Drugs R D 2007; 8: 301-314
2. Azevedo M. Topical levocabastine-A review of therapeutic efficacy compared with topical sodium cromoglycate and oral terfenadine on days with high pollen counts. Mediators Inflamm 1995; 4: S21-25
3. Zhang MQ, Timmerman H. Terfenadine: a mixture of equipotent antihistamine enantiomers without a clear isomeric ballast. Pharm World Sci 1993; 15: 186-192
4. Aaronson DW. Effects of terfenadine on psychomotor performance. An overview. Drug Saf 1993; 8: 321-329
5. Jankowski R, Wagenmann M, Baroody FM, Naclerio R. Effect of terfenadine on nasal provocation. Int Arch Allergy Immunol 1993; 101: 311-317
6. McTavish D, Goa KL, Ferrill M. Terfenadine. An updated review of its pharmacological properties and therapeutic efficacy. Drugs 1990; 39: 552-574
7. Carter CA, Wojciechowski NJ, Hayes JM, Skoutakis VA, Rickman LA. Terfenadine, a nonsedating antihistamine. Drug Intell Clin Pharm 1985; 19: 812-817
8. Sorkin EM, Heel RC. Terfenadine A review of its pharmacodynamic properties and therapeutic efficacy. Drugs 1985; 29: 34-56
9. Ciprandi G, Iudice A, Tosca MA, Ruffoni S, Buscaglia S, Canonica GW. Comparative effects of terfenadine and loratadine in the treatment of hay fever. J Investig Allergol Clin Immunol 1991; 1: 368-372
10. Brooks CD, Karl KJ, Francom SF. Profile of ragweed hay fever symptom control with terfenadine started before or after symptoms are established. Clin Exp Allergy 1990; 20: 21-26
11. Jangi SM, Ruiz-Larrea MB, Nicolau-Galmes F, Andollo N, Arroyo-Berdugo Y, Ortega-Martinez I, Diaz-Perez JL, Boyano MD. Terfenadine-induced apoptosis in human melanoma cells is mediated through Ca2+ homeostasis modulation and tyrosine kinase activity, independently of H1 histamine receptors. Carcinogenesis 2008; 29: 500-509
12. Nicolau-Galmes F, Asumendi A, Alonso-Tejerina E, Perez-Yarza G, Jangi SM, Gardeazabal J, Arroyo-Berdugo Y, Careaga JM, Diaz-Ramon JL, Apraiz A, Boyano MD. Terfenadine induces apoptosis and autophagy in melanoma cells through ROS-dependent and-independent mechanisms. Apoptosis 2011; 16: 1253-1267
13. Wang WT, Chen YH, Hsu JL, Leu WJ, Yu CC, Chan SH, Ho YF, Hsu LC, Guh JH. Terfenadine induces anti-proliferative and apoptotic activities in human hormone-refractory prostate cancer through histamine receptor-independent Mcl-1 cleavage and Bak up-regulation. Naunyn Schmiedebergs Arch Pharmacol 2014; 387: 33-45
14. Blaya B, Nicolau-Galmes F, Jangi SM, Ortega-Martinez I, Alonso-Tejerina E, Burgos-Bretones J, Perez-Yarza G, Asumendi A, Boyano MD. Histamine and histamine receptor antagonists in cancer biology. Inflamm Allergy Drug Targets 2010; 9: 146-157
15. Chen C, Li G, Liao W, Wu J, Liu L, Ma D, Zhou J, Elbekai RH, Edin ML, Zeldin DC, Wang DW. Selective inhibitors of CYP2J2 related to terfenadine exhibit strong activity against human cancers in vitro and in vivo. J Pharmacol Exp Ther 2009; 329: 908-918
16. Jangi SM, Diaz-Perez JL, Ochoa-Lizarralde B, Martin-Ruiz I, Asumendi A, Perez-Yarza G, Gardeazabal J, Diaz-Ramon JL, Boyano MD. H1 histamine receptor antagonists induce genotoxic and caspase-2-dependent apoptosis in human melanoma cells. Carcinogenesis 2006; 27: 1787-1796
17. Liu JD, Wang YJ, Chen CH, Yu CF, Chen LC, Lin JK, Liang YC, Lin SY, Ho YS. Molecular mechanisms of G0/G1 cell-cycle arrest and apoptosis induced by terfenadine in human cancer cells. Mol Carcinog 2003; 37: 39-50
18. Wang YJ, Yu CF, Chen LC, Chen CH, Lin JK, Liang YC, Lin CH, Lin SY, Chen CF, Ho YS. Ketoconazole potentiates terfenadine-induced apoptosis in human Hep G2 cells through inhibition of cytochrome p450 3A4 activity. J Cell Biochem 2002; 87: 147-159
19. Hadzijusufovic E, Peter B, Gleixner KV, Schuch K, Pickl WF, Thaiwong T, Yuzbasiyan-Gurkan V, Mirkina I, Willmann M, Valent P. H1-receptor antagonists terfenadine and loratadine inhibit spontaneous growth of neoplastic mast cells. Exp Hematol 2010; 38: 896-907
20. Aichberger KJ, Mayerhofer M, Vales A, Krauth MT, Gleixner KV, Bilban M, Esterbauer H, Sonneck K, Florian S, Derdak S, Pickl WF, Agis H, Falus A, Sillaber C, Valent P. The CML-related oncoprotein BCR/ABL induces expression of histidine decarboxylase (HDC) and the synthesis of histamine in leukemic cells. Blood 2006; 108: 3538-3547
21. Modlin IM, Lawton GP, Tang LH, Geibel J, Abraham R, Darr U. The mastomys gastric carcinoid: aspects of enterochromaffin-like cell function. Digestion 1994; 55: S31-37
22. Lang PA, Kaiser S, Myssina S, Wieder T, Lang F, Huber SM. Role of Ca2+-Activated K+ channels in human erythrocyte apoptosis. Am J Physiol Cell Physiol 2003; 285: C1553-C1560
23. Lang E, Lang F. Mechanisms and pathophysiological significance of eryptosis, the suicidal erythrocyte death. Semin Cell Dev Biol 2015; 39: 35-42
24. Abed M, Towhid ST, Mia S, Pakladok T, Alesutan I, Borst O, Gawaz M, Gulbins E, Lang F. Sphingomyelinase-induced adhesion of eryptotic erythrocytes to endothelial cells. Am J Physiol Cell Physiol 2012; 303: C991-999
25. Lau IP, Chen H, Wang J, Ong HC, Leung KC, Ho HP, Kong SK. In vitro effect of CTAB-And PEG-coated gold nanorods on the induction of eryptosis/erythroptosis in human erythrocytes. Nanotoxicology 2012; 6: 847-856
26. Maellaro E, Leoncini S, Moretti D, Del Bello B, Tanganelli I, De Felice C, Ciccoli L. Erythrocyte caspase-3 activation and oxidative imbalance in erythrocytes and in plasma of type 2 diabetic patients. Acta Diabetol 2013; 50: 489-495
27. Abed M, Feger M, Alzoubi K, Pakladok T, Frauenfeld L, Geiger C, Towhid ST, Lang F. Sensitization of erythrocytes to suicidal erythrocyte death following water deprivation. Kidney Blood Press Res 2013; 37: 567-578
28. Voelkl J, Alzoubi K, Mamar AK, Ahmed MS, Abed M, Lang F. Stimulation of suicidal erythrocyte death by increased extracellular phosphate concentrations. Kidney Blood Press Res 2013; 38: 42-51
29. Abed M, Artunc F, Alzoubi K, Honisch S, Baumann D, Foller M, Lang F. Suicidal erythrocyte death in end-stage renal disease. J Mol Med (Berl) 2014; 92: 871-879
30. Ahmed MS, Langer H, Abed M, Voelkl J, Lang F. The uremic toxin acrolein promotes suicidal erythrocyte death. Kidney Blood Press Res 2013; 37: 158-167
31. Polak-Jonkisz D, Purzyc L. Ca(2+) influx versus efflux during eryptosis in uremic erythrocytes. Blood Purif 2012; 34: 209-210; author reply 210
32. Calderon-Salinas JV, Munoz-Reyes EG, Guerrero-Romero JF, Rodriguez-Moran M, Bracho-Riquelme RL, Carrera-Gracia MA, Quintanar-Escorza MA. Eryptosis and oxidative damage in type 2 diabetic mellitus patients with chronic kidney disease. Mol Cell Biochem 2011; 357: 171-179
33. Lang PA, Beringer O, Nicolay JP, Amon O, Kempe DS, Hermle T, Attanasio P, Akel A, Schafer R, Friedrich B, Risler T, Baur M, Olbricht CJ, Zimmerhackl LB, Zipfel PF, Wieder T, Lang F. Suicidal death of erythrocytes in recurrent hemolytic uremic syndrome. J Mol Med (Berl) 2006; 84: 378-388
34. Nicolay JP, Schneider J, Niemoeller OM, Artunc F, Portero-Otin M, Haik G, Jr., Thornalley PJ, Schleicher E, Wieder T, Lang F. Stimulation of suicidal erythrocyte death by methylglyoxal. Cell Physiol Biochem 2006; 18: 223-232
35. Lang E, Gatidis S, Freise NF, Bock H, Kubitz R, Lauermann C, Orth HM, Klindt C, Schuier M, Keitel V, Reich M, Liu G, Schmidt S, Xu HC, Qadri SM, Herebian D, Pandyra AA, Mayatepek E, Gulbins E, Lang F, Haussinger D, Lang KS, Foller M, Lang PA. Conjugated bilirubin triggers anemia by inducing erythrocyte death. Hepatology 2015; 61: 275-284
36. Kempe DS, Akel A, Lang PA, Hermle T, Biswas R, Muresanu J, Friedrich B, Dreischer P, Wolz C, Schumacher U, Peschel A, Gotz F, Doring G, Wieder T, Gulbins E, Lang F. Suicidal erythrocyte death in sepsis. J Mol Med (Berl) 2007; 85: 273-281
37. Lang PA, Schenck M, Nicolay JP, Becker JU, Kempe DS, Lupescu A, Koka S, Eisele K, Klarl BA, Rubben H, Schmid KW, Mann K, Hildenbrand S, Hefter H, Huber SM, Wieder T, Erhardt A, Haussinger D, Gulbins E, Lang F. Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide. Nat Med 2007; 13: 164-170
38. Alzoubi K, Calabròa S, Bissinger R, Abed M, Faggio C, Lang F. Stimulation of Suicidal Erythrocyte Death by Artesunate. Cell Physiol Biochem 2014; 34: 2232-2244
39. Alzoubi K, Egler J, Abed M, Lang F. Enhanced Eryptosis Following Auranofin Exposure. Cell Physiol Biochem 2015; 37: 1018-1028
40. Arnold M, Bissinger R, Lang F. Mitoxantrone-induced suicidal erythrocyte death. Cell Physiol Biochem 2014; 34: 1756-1767
41. Arnold M, Lang E, Modicano P, Bissinger R, Faggio C, Abed M, Lang F. Effect of nitazoxanide on erythrocytes. Basic Clin Pharmacol Toxicol 2014; 114: 421-426
42. Bissinger R, Barking S, Alzoubi K, Liu G, Liu G, Lang F. Stimulation of Suicidal Erythrocyte Death by the Antimalarial Drug Mefloquine. Cell Physiol Biochem 2015; 36: 1395-1405
43. Bissinger R, Bouguerra G, Stockinger K, Abbes S, Lang F. Triggering of Suicidal Erythrocyte Death by Topotecan. Cell Physiol Biochem 2015; 37: 1607-1618
44. Bissinger R, Fischer S, Jilani K, Lang F. Stimulation of Erythrocyte Death by Phloretin. Cell Physiol Biochem 2014; 34: 2256-2265
45. Jacobi J, Lang E, Bissinger R, Frauenfeld L, Modicano P, Faggio C, Abed M, Lang F. Stimulation of erythrocyte cell membrane scrambling by mitotane. Cell Physiol Biochem 2014; 33: 1516-1526
46. Bouguerra G, Aljanadi O, Bissinger R, Abbes S, Lang F. Embelin-Induced Phosphatidylserine Translocation in the Erythrocyte Cell Membrane. Cell Physiol Biochem 2015; 37: 1629-1640
47. Bouguerra G, Bissinger R, Abbes S, Lang F. Stimulation of Eryptosis by Narasin. Cell Physiol Biochem 2015; 37: 1807-1816
48. Bouguerra G, Bissinger R, Abbes S, Lang F. Zopolrestat Induced Suicidal Death of Human Erythrocytes. Cell Physiol Biochem 2015; 37: 1537-1546
49. Briglia M, Fazio A, Faggio C, Laufer S, Alzoubi K, Lang F. Triggering of Suicidal Erythrocyte Death by Ruxolitinib. Cell Physiol Biochem 2015; 37: 768-778
50. Briglia M, Fazio A, Signoretto E, Faggio C, Lang F. Edelfosine Induced Suicidal Death of Human Erythrocytes. Cell Physiol Biochem 2015; 37: 2221-2230
51. Calabro S, Alzoubi K, Faggio C, Laufer S, Lang F. Triggering of Suicidal Erythrocyte Death Following Boswellic Acid Exposure. Cell Physiol Biochem 2015; 37: 131-142
52. Egler J, Lang F. Licochalcone A Induced Suicidal Death of Human Erythrocytes. Cell Physiol Biochem 2015; 37: 2060-2070
53. Faggio C, Alzoubi K, Calabro S, Lang F. Stimulation of suicidal erythrocyte death by PRIMA-1. Cell Physiol Biochem 2015; 35: 529-540
54. Fazio A, Briglia M, Faggio C, Alzoubi K, Lang F. Stimulation of Suicidal Erythrocyte Death by Garcinol. Cell Physiol Biochem 2015; 37: 805-815
55. Lang E, Jilani K, Bissinger R, Rexhepaj R, Zelenak C, Lupescu A, Lang F, Qadri SM. Vitamin D-Rich Diet in Mice Modulates Erythrocyte Survival. Kidney Blood Press Res 2015; 40: 403-412
56. Lang E, Zelenak C, Eberhard M, Bissinger R, Rotte A, Ghashghaeinia M, Lupescu A, Lang F, Qadri SM. Impact of Cyclin-Dependent Kinase CDK4 Inhibition on Eryptosis. Cell Physiol Biochem 2015; 37: 1178-1186
57. Lupescu A, Bissinger R, Goebel T, Salker MS, Alzoubi K, Liu G, Chirigiu L, Mack AF, Qadri SM, Lang F. Enhanced suicidal erythrocyte death contributing to anemia in the elderly. Cell Physiol Biochem 2015; 36: 773-783
58. Lupescu A, Bissinger R, Herrmann T, Oswald G, Jilani K, Lang F. Induction of suicidal erythrocyte death by novobiocin. Cell Physiol Biochem 2014; 33: 670-680
59. Malik A, Bissinger R, Calabro S, Faggio C, Jilani K, Lang F. Aristolochic Acid Induced Suicidal Erythrocyte Death. Kidney Blood Press Res 2014; 39: 408-419
60. Officioso A, Alzoubi K, Manna C, Lang F. Clofazimine Induced Suicidal Death of Human Erythrocytes. Cell Physiol Biochem 2015; 37: 331-341
61. Oswald G, Alzoubi K, Abed M, Lang F. Stimulation of suicidal erythrocyte death by ribavirin. Basic Clin Pharmacol Toxicol 2014; 114: 311-317
62. Peter T, Bissinger R, Enkel S, Alzoubi K, Oswald G, Lang F. Programmed erythrocyte death following in vitro Treosulfan treatment. Cell Physiol Biochem 2015; 35: 1372-1380
63. Stockinger K, Bissinger R, Bouguerra G, Abbes S, Lang F. Enhanced Eryptosis Following Exposure to Carnosic Acid. Cell Physiol Biochem 2015; 37: 1779-1791
64. Tesoriere L, Attanzio A, Allegra M, Cilla A, Gentile C, Livrea MA. Oxysterol mixture in hypercholesterolemia-relevant proportion causes oxidative stress-dependent eryptosis. Cell Physiol Biochem 2014; 34: 1075-1089
65. Waibel S, Bissinger R, Bouguerra G, Abbes S, Lang F. Saquinavir Induced Suicidal Death of Human Erythrocytes. Cell Physiol Biochem 2015; 37: 1973-1982
66. Zierle J, Bissinger R, Egler J, Lang F. Lapatinib Induced Suicidal Death of Human Erythrocytes. Cell Physiol Biochem 2015; 37: 2275-2287
67. Carlson AM, Morris LS. Coprescription of terfenadine and erythromycin or ketaconazole: an assessment of potential harm. J Am Pharm Assoc (Wash) 1996; NS36: 263-269
68. Thompson D, Oster G. Use of terfenadine and contraindicated drugs. JAMA 1996; 275: 1339-1341
69. Harrison HE, Bunting H, Ordway NK, Albrink WS. The Pathogenesis of the Renal Injury Produced in the Dog by Hemoglobin or Methemoglobin. J Exp Med 1947; 86: 339-356
70. Borst O, Abed M, Alesutan I, Towhid ST, Qadri SM, Foller M, Gawaz M, Lang F. Dynamic adhesion of eryptotic erythrocytes to endothelial cells via CXCL16/SR-PSOX. Am J Physiol Cell Physiol 2012; 302: C644-C651
71. Andrews DA, Low PS. Role of red blood cells in thrombosis. Curr Opin Hematol 1999; 6: 76-82
72. Chung SM, Bae ON, Lim KM, Noh JY, Lee MY, Jung YS, Chung JH. Lysophosphatidic acid induces thrombogenic activity through phosphatidylserine exposure and procoagulant microvesicle generation in human erythrocytes. Arterioscler Thromb Vasc Biol 2007; 27: 414-421
73. Zwaal RF, Comfurius P, Bevers EM. Surface exposure of phosphatidylserine in pathological cells. Cell Mol Life Sci 2005; 62: 971-988
74. Closse C, Dachary-Prigent J, Boisseau MR. Phosphatidylserine-related adhesion of human erythrocytes to vascular endothelium. Br J Haematol 1999; 107: 300-302
75. Gallagher PG, Chang SH, Rettig MP, Neely JE, Hillery CA, Smith BD, Low PS. Altered erythrocyte endothelial adherence and membrane phospholipid asymmetry in hereditary hydrocytosis. Blood 2003; 101: 4625-4627
76. Pandolfi A, Di Pietro N, Sirolli V, Giardinelli A, Di Silvestre S, Amoroso L, Di Tomo P, Capani F, Consoli A, Bonomini M. Mechanisms of uremic erythrocyte-induced adhesion of human monocytes to cultured endothelial cells. J Cell Physiol 2007; 213: 699-709
77. Wood BL, Gibson DF, Tait JF. Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. Blood 1996; 88: 1873-1880